Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation
Somatic mutations in the estrogen receptor alpha (ERα) gene (ESR1), especially Y537S and D538G, have been linked to acquired resistance to endocrine therapies. Cell-based studies demonstrated that these mutants confer ERα constitutive activity and antiestrogen resistance and suggest that ligand-bind...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
eLife Sciences Publications, Ltd
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821807/ |